Pricing Guide

Wegovy Cost

Affordable GLP-1 weight loss medication starting at $199/mo. Licensed providers, free shipping.

Take the Free Quiz

Free consultation · No commitment · Results in weeks

Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · Wegovy Cost is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant
Updated June 2026Medically reviewed by licensed providers

Wegovy Cost: Weight Method offers compounded GLP-1 treatment starting at $199/month. Compounded semaglutide from $199/month and tirzepatide from $329/month, prescribed by licensed providers. Includes virtual medical consultation and free direct shipping.

Key Fact

Weight Method's compounded semaglutide program is $154/month ($1,848/year), all-inclusive, with no insurance required. Weight Method does not dispense brand-name Wegovy®. Wegovy is FDA-approved; compounded semaglutide is not FDA-approved.

Source: Weight Method pricing, February 2026

How much does treatment cost per month?

Wegovy's pricing at a retail pharmacy reflects Novo Nordisk's pricing for a weight-management-specific FDA-approved indication. The five-pen dose-escalation kit (0.25mg through 2.4mg) is priced uniformly regardless of dose, meaning patients pay the same retail price during the low-dose initiation phase as at the maintenance dose. The insurance landscape for Wegovy is fragmented. Some employers have proactively added anti-obesity medication coverage, recognizing the long-term healthcare implications. Others have explicitly excluded it. Medicare Part D does not cover Wegovy for weight loss. Medicaid coverage varies by state, with most states excluding anti-obesity drugs. For patients with commercial coverage, an annual deductible must typically be met before copay rates apply. Weight Method's $154/month compounded semaglutide pricing is a flat all-inclusive monthly fee. There is no deductible, no prior authorization period, and no annual formulary surprises. Compounded semaglutide is not FDA-approved.

How can you save on treatment?

Weight Method's compounded semaglutide program is a flat $154/month all-inclusive fee. Brand-name Wegovy purchased cash-pay at a retail pharmacy is set by Novo Nordisk and accumulates a much larger annual cash outlay for patients without coverage. The decision between them is not purely financial — Wegovy is FDA-approved (with the FDA review process that designation entails), while compounded semaglutide is not. Published clinical-trial outcomes describe brand-name Wegovy at the 2.4mg maintenance dose. Those outcomes were generated with the FDA-approved product and should not be assumed to apply to compounded semaglutide, which is not FDA-evaluated. Your provider can discuss what to expect from compounded therapy based on your individual clinical profile. Non-financial considerations matter too. Patients on the conventional pathway report 3-6 weeks from prescription to first dose, including prior authorization processing and pharmacy coordination. Weight Method patients typically begin treatment within days.

Ready to Get Started?

Answer a few quick questions to see if you qualify for GLP-1 medication.

Check Eligibility

Your Treatment Options

Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Starting at$199/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Compounded semaglutide. Once-weekly subcutaneous injection.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

Brand-name Wegovy purchased cash-pay at a retail pharmacy is set by the manufacturer and is among the highest monthly prescription costs without coverage; with insurance, copays vary by plan and apply only after the deductible is met. Weight Method's compounded semaglutide program is $154/month, all-inclusive, with no insurance required. Compounded semaglutide is not FDA-approved.

Medicare Part D historically does not cover medications prescribed for weight management, including Wegovy. Coverage policy is evolving; check with your plan.

Both are FDA-approved Novo Nordisk products containing semaglutide, with different labeled indications and dosing. Wegovy is FDA-approved for chronic weight management (dosed up to 2.4mg). Ozempic is FDA-approved for type 2 diabetes (dosed up to 2mg). The active ingredient is the same; the indications and doses differ.

Novo Nordisk offers a savings card for some commercially insured patients with annual caps and time limits; it excludes government insurance. The savings card applies only to brand-name Wegovy.

No. Wegovy® is the FDA-approved brand-name medication manufactured by Novo Nordisk. Compounded semaglutide is prepared by a U.S.-licensed 503A compounding pharmacy pursuant to a patient-specific prescription. Compounded medications are not FDA-approved; the FDA has not reviewed them for safety, efficacy, or manufacturing quality. Published clinical-trial outcomes describe brand-name Wegovy specifically, not the compounded product.

Get GLP-1 at the Best Price

We offer the most affordable GLP-1 treatments. Starting at $199/month.

See Pricing

Free consultation. No commitment.

Other Cost Guides

Wegovy Cost by State